SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-22-005621
Filing Date
2022-04-29
Accepted
2022-04-29 11:43:40
Documents
13
Period of Report
2022-04-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k_proxy.htm 6-K 20219
2 EXHIBIT 99.1 ex991.htm EX-99.1 33385
3 EXHIBIT 99.2 ex992.htm EX-99.2 476384
4 EXHIBIT 99.3 ex993.htm EX-99.3 7947
5 EXHIBIT 99.4 ex994.htm EX-99.4 2443
6 EXHIBIT 99.5 ex995.htm EX-99.5 13917
7 IMAGE ex994000.jpg GRAPHIC 62652
8 IMAGE ex994001.jpg GRAPHIC 131394
9 IMAGE graph.jpg GRAPHIC 46205
10 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
11 IMAGE logotsxtrust.jpg GRAPHIC 5303
12 IMAGE tmxlogo.jpg GRAPHIC 2389
13 IMAGE tsxtrustlogo.jpg GRAPHIC 2125
  Complete submission text file 0001654954-22-005621.txt   910672
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 22872012
SIC: 2834 Pharmaceutical Preparations